Casper Sleep Cuts IPO Price While Beam Lifts Target
Mattress company Casper Sleep on Wednesday downsized its expectations for its Latham-steered initial public offering, while biotechnology company Beam Therapeutics bulked up its plans for its Ropes & Gray-steered debut....To view the full article, register now.
Already a subscriber? Click here to view full article